Cite

    Wu, K. et al. (n.d.). Rapamycin interacts synergistically with idarubicin to induce T-leukemia cell apoptosis in vitro and in a mesenchymal stem cell simulated drug-resistant microenvironment via Akt/mammalian target of rapamycin and extracellular signal-related kinase signaling pathways. Leukemia & lymphoma. 55 (3), pp. 668-676. [Online].